Emergent BioSolutions Reports Fourth Quarter and Full Year 2018 Financial Results

    NEXT STORY
    Moleculin Biotech, Inc. Reports Financial Results for the Year Ended December 31, 2018
    PREV STORY
    Trillium Announces Proposed Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioSig Appoints Barry Keenan as Vice President of Engineering

    author_avatar
    NASDAQ Market News

    American Health Council Names Sarah Forsythe, MS, RN, BSN to Nursing Board

    NEW YORK, Nov. 18, 2016 (GLOBE NEWSWIRE) -- Sarah Forsythe, Clinical Quality Specialist at ...

    author_avatar
    NASDAQ Market News

    Cempra to Present at Two Upcoming Investor Conferences

    CHAPEL HILL, N.C., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

    author_avatar
    NASDAQ Market News